Laura Chico
Stock Analyst at Wedbush
(4.77)
# 595
Out of 4,453 analysts
599
Total ratings
53.9%
Success rate
14.3%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics | Maintained: Buy | $55 → $61 | $59.03 | +3.34% | 33 | Jun 22, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $52 | $41.69 | +24.73% | 25 | Jun 17, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $105 | $91.57 | +14.67% | 15 | Jun 15, 2026 | |
| CLYM Climb Bio | Maintained: Buy | $17 | $12.66 | +34.28% | 4 | Jun 12, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Sell | $166 → $162 | $327.86 | -50.59% | 24 | Jun 2, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $34 → $45 | $21.81 | +106.33% | 10 | Jun 2, 2026 | |
| GOSS Gossamer Bio | Maintained: Hold | $1 | $0.1652 | +505.33% | 6 | May 19, 2026 | |
| BIIB Biogen | Maintained: Hold | $196 | $201.96 | -2.95% | 67 | May 18, 2026 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $13 → $12 | $3.50 | +242.86% | 6 | May 18, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | $17 → $16 | $8.86 | +80.59% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $42.77 | +23.92% | 3 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $25.30 | -5.14% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.42 | +189.26% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $33.30 | +26.13% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $1.71 | +133.92% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $48 | $27.02 | +77.65% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $18.41 | +117.27% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $26 | $29.25 | -11.11% | 52 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $56.78 | +10.95% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $23 | $24.73 | -7.00% | 26 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $30.40 | +25.00% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $21 | $9.90 | +112.12% | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $32 | $17.39 | +84.01% | 71 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $151 → $166 | $164.18 | +1.11% | 23 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $23 | $40.50 | n/a | 8 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.06 | n/a | 18 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $3.55 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $15.71 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $13.44 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $5 | $6.21 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.33 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $45 | $1.05 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.35 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $480.18 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.07 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.53 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $620.14 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $8.25 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.07 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.27 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $2.36 | n/a | 1 | Jun 30, 2017 |
Travere Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $55 → $61
Current: $59.03
Upside: +3.34%
Edgewise Therapeutics
Jun 17, 2026
Maintained: Buy
Price Target: $52
Current: $41.69
Upside: +24.73%
Dianthus Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $105
Current: $91.57
Upside: +14.67%
Climb Bio
Jun 12, 2026
Maintained: Buy
Price Target: $17
Current: $12.66
Upside: +34.28%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Sell
Price Target: $166 → $162
Current: $327.86
Upside: -50.59%
Jade Biosciences
Jun 2, 2026
Maintained: Buy
Price Target: $34 → $45
Current: $21.81
Upside: +106.33%
Gossamer Bio
May 19, 2026
Maintained: Hold
Price Target: $1
Current: $0.1652
Upside: +505.33%
Biogen
May 18, 2026
Maintained: Hold
Price Target: $196
Current: $201.96
Upside: -2.95%
Larimar Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $13 → $12
Current: $3.50
Upside: +242.86%
Solid Biosciences
May 18, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $8.86
Upside: +80.59%
May 18, 2026
Maintained: Buy
Price Target: $53
Current: $42.77
Upside: +23.92%
May 14, 2026
Maintained: Hold
Price Target: $21 → $24
Current: $25.30
Upside: -5.14%
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $2.42
Upside: +189.26%
May 13, 2026
Maintained: Buy
Price Target: $42
Current: $33.30
Upside: +26.13%
May 13, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $1.71
Upside: +133.92%
May 13, 2026
Maintained: Buy
Price Target: $58 → $48
Current: $27.02
Upside: +77.65%
May 12, 2026
Reiterated: Buy
Price Target: $40
Current: $18.41
Upside: +117.27%
May 8, 2026
Maintained: Hold
Price Target: $25 → $26
Current: $29.25
Upside: -11.11%
May 8, 2026
Maintained: Buy
Price Target: $63
Current: $56.78
Upside: +10.95%
May 8, 2026
Maintained: Buy
Price Target: $30 → $23
Current: $24.73
Upside: -7.00%
May 8, 2026
Maintained: Buy
Price Target: $38
Current: $30.40
Upside: +25.00%
May 7, 2026
Maintained: Buy
Price Target: $22 → $21
Current: $9.90
Upside: +112.12%
May 5, 2026
Maintained: Buy
Price Target: $31 → $32
Current: $17.39
Upside: +84.01%
Apr 7, 2026
Maintained: Buy
Price Target: $151 → $166
Current: $164.18
Upside: +1.11%
Jun 9, 2025
Maintained: Hold
Price Target: $34 → $23
Current: $40.50
Upside: n/a
Nov 1, 2024
Maintained: Buy
Price Target: $11
Current: $6.06
Upside: n/a
Aug 7, 2024
Maintained: Hold
Price Target: $8 → $7
Current: $3.55
Upside: n/a
Apr 11, 2024
Maintained: Buy
Price Target: $13 → $11
Current: $15.71
Upside: n/a
Mar 20, 2024
Maintained: Hold
Price Target: $5
Current: $13.44
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $22 → $5
Current: $6.21
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $23
Current: $4.33
Upside: n/a
Aug 11, 2020
Maintained: Hold
Price Target: $3 → $45
Current: $1.05
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $57.35
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $480.18
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $15.07
Upside: n/a
Aug 13, 2018
Maintained: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: n/a
Current: $620.14
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $8.25
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.07
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $42.27
Upside: n/a
Jun 30, 2017
Maintained: Buy
Price Target: $30
Current: $2.36
Upside: n/a